- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/563 - ImmunoassayBiospecific binding assayMaterials therefor involving antibody fragments
Patent holdings for IPC class G01N 33/563
Total number of patents in this class: 410
10-year publication summary
9
|
14
|
16
|
26
|
35
|
46
|
28
|
36
|
23
|
16
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 20137 |
9 |
ARK Diagnostics, Inc. | 34 |
8 |
IDEXX Laboratories, Inc. | 848 |
5 |
Redcoat Solutions, Inc. | 13 |
4 |
Regeneron Pharmaceuticals, Inc. | 4362 |
4 |
The Rockefeller University | 566 |
4 |
Hoffmann-La Roche Inc. | 3484 |
3 |
Becton, Dickinson and Company | 7321 |
3 |
Agilent Technologies, Inc. | 2632 |
3 |
Board of Regents, The University of Texas System | 5884 |
3 |
The Johns Hopkins University | 5723 |
3 |
Agency for Science, Technology and Research | 3659 |
3 |
The Brigham and Women's Hospital, Inc. | 2217 |
3 |
InBios International, Inc. | 32 |
3 |
Kookmin University Industry Academy Cooperation Foundation | 395 |
3 |
Nour Heart, Inc. | 16 |
3 |
SRI International | 995 |
3 |
Temasek Life Sciences Laboratory Limited | 142 |
3 |
University Health Network | 1051 |
3 |
Neuracle Science Co., Ltd. | 64 |
3 |
Other owners | 334 |